Detection and Characterization of Circulating Tumour Cells in Multiple Myeloma.

about

Detection and Characterization of Circulating Tumour Cells in Multiple Myeloma.

Item

http://www.wikidata.org/entity/Q55208548

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Detection and Characterization of Circulating Tumour Cells in Multiple Myeloma.

@en

Detection and Characterization of Circulating Tumour Cells in Multiple Myeloma.

@nl

type

Item

label

Detection and Characterization of Circulating Tumour Cells in Multiple Myeloma.

@en

Detection and Characterization of Circulating Tumour Cells in Multiple Myeloma.

@nl

prefLabel

Detection and Characterization of Circulating Tumour Cells in Multiple Myeloma.

@en

Detection and Characterization of Circulating Tumour Cells in Multiple Myeloma.

@nl

P1476

Detection and Characterization of Circulating Tumour Cells in Multiple Myeloma.

@en

P2093

Dena Marrinucci

http://www.w3.org/2001/XMLSchema#string

Florence Y Lee

http://www.w3.org/2001/XMLSchema#string

Liangxuan Zhang

http://www.w3.org/2001/XMLSchema#string

Natalie L Prigozhina

http://www.w3.org/2001/XMLSchema#string

Renee Higgins

http://www.w3.org/2001/XMLSchema#string

Sharon Beasley

http://www.w3.org/2001/XMLSchema#string

Shidong Jia

http://www.w3.org/2001/XMLSchema#string

Shoji Ikeda

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization of clonogenic multiple myeloma cells

High-definition imaging of circulating tumor cells and associated cellular events in non-small cell lung cancer patients: a longitudinal analysis

Fluid biopsy in patients with metastatic prostate, pancreatic and breast cancers

Deciphering intratumor heterogeneity and temporal acquisition of driver events to refine precision medicine

The promise of circulating tumor cell analysis in cancer management

New criteria for response assessment: role of minimal residual disease in multiple myeloma

Mutational landscape and significance across 12 major cancer types

Clonal evolution in cancer

The causes and consequences of genetic heterogeneity in cancer evolution

Bortezomib in multiple myeloma: systematic review and clinical considerations.

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5772/64124

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28936258

http://www.w3.org/2001/XMLSchema#string

P932

5548310

http://www.w3.org/2001/XMLSchema#string